Copper intrauterine contraception for emergency contraception: a prospective multicentre study

World Health Organization (WHO) (Switzerland)0 sites2,000 target enrollmentJanuary 19, 2010

Overview

No summary available.

Registry

who.int

Start Date

January 19, 2010

End Date

TBD

Last Updated

11 years ago

Study Type

Interventional

Sex

Female

Sponsor

World Health Organization (WHO) (Switzerland)

•1\. Requesting emergency contraception within 120 hour of unprotected intercourse
•2\. Regular menstrual cycles (24 to 42 days with no more than 5 days variation)
•3\. Having at least one spontaneous cycle before current cycle after recent discontinued hormonal contraception, abortion or delivery
•4\. Desire to use IUD as long term contraceptive
•5\. Available for follow up in one month, three months and 12 months
•6\. Negative pregnancy test
•7\. Aged 18 \- 44 years

•1\. Suspected or confirmed pregnancy
•2\. Any episode of pelvic inflammatory disease (PID) or pelvic abscess in the 12 months preceding trial admission
•3\. Sexually transmitted infection (STI) within the past six months
•4\. Any evidence of STI in clinical or laboratory examination during screening
•5\. Multiple sexual partners
•6\. Known or suspected genital tract malignancy
•7\. Cervical or uterine malformations
•8\. Vaginal bleeding of unknown aetiology
•9\. Multiple uterine fibroids associated with previous menstrual anomalies
•10\. Clinical or laboratory evidence of anaemia (haemoglobin less than 9 g/l)